Searched for
MARKET LEADER PHARMEASY
Drugs at your door: Signs of a disruption taking shape in IndiaIndia Pharmacy Retail Quick Commerce: India's medicine delivery is seeing a change. Quick-commerce apps are making it easier to buy medicin...- Tata 1mg plans more offline forays as it looks to raise $300 millionTata 1mg is entering a new growth phase with plans to expand offline and raise $300 million in external funding. Backed by Tata Digital, th...
- Zepto CEO Aadit Palicha's interview; Lisa Su on AMD's India plansHappy Friday! Zepto CEO on growth, cash burn, foreign ownership and impact on kiranas. This and more in today’s ETtech Morning Dispatch.
- Tata 1mg’s FY24 operating revenue up 21% to Rs 1,968 croreTata 1mg’s net loss plummeted to Rs 313 crore from Rs 1,255 crore in the previous financial year. Over 80% of the company’s operating reven...
- Tata funds pause is no 'debt-errent' at 1mg, BigBasketBigBasket and 1mg–two of the biggest digital assets of Tata group–are choosing debt over equity for expansion in a critical year for them. ...
- 1mg overtakes PharmEasy in market share in top order changeTata 1mg had a 31% market share in September 2023 against 19% in October 2022 while PharmEasy slipped to 15% from about 33% during the same...
- Apple flags ‘state-sponsored’ hacking, govt orders probe; inside PharmEasy’s Rs 3,500-crore rights issueThe Centre has ordered probe after opposition members, journalists received messages on their iPhones, warning them of possible ‘state-spon...
- PharmEasy mails health minister for quick draft rules notificationPharmEasy parent API Holdings wrote to health minister Mansukh Mandaviya asking for an urgent meeting with the delegation of online pharmac...
- BharatPe saga just won’t quit; PharmEasy may revise IPO valuationSeveral sources have told us that head of controls Madhuri Jain – who is also cofounder Ashneer Grover’s wife – wrote to the company board ...
- Lal PathLabs can fortify its hold if suburban is integrated wellDr Lal PathLabs (LPL), India's largest diagnostics player by revenue and presence, is slated to become bigger with the acquisition of Subur...
- Trifecta Capital invests Rs 400 crore in four Indian tech companiesThe fund has invested in ixigo, Good Glamm Group (MyGlamm), API Holdings (PharmEasy), and Meesho, in line with its strategy to back growth ...
- Freshworks IPO details; Uber's Dutch setbackSaaS startup Freshworks is hoping for a valuation of $9 billion for its US IPO. Uber Technologies has lost another lawsuit over its drivers...
- Flush with funds, Indian unicorns on a talent huntOf these, 14 companies told ET that they were looking to ramp up headcount, across product, technology, data analytics, customer support, s...
- Metal stocks unlikely to continue up move: Sandip Sabharwal“The risk reward right now is not in favour. People need to buy at lower prices to make any sort of decent returns.”
- PharmEasy’s $300M booster shotIn today’s ETtech Morning Dispatch: Ant Group may face India curbs after IPOs of Zomato and Paytm, Twitter’s troubles in India continue, Co...
- PharmEasy to acquire ThyrocareFrom Pharmeasy-Thyrocare deal to Twitter briefly locking IT minister's account and China's role in 2021's crypto collapse, here's a quick l...
- Amazon, Flipkart challenge court orderFrom Amazon and Flipkart challenging HC order on CCI's antitrust probe to Twitter's standoff with govt and Satya Nadella elected as board c...
- Final countdownFrom Facebook's IT rules discussions with the govt to FarEye's big funding round and PharmEasy buying Medlife, here's a quick look at the t...
- Eight Roads Ventures names two new venture partnersThe investment firm, which already counts Icertis, Whatfix, MoEngage, FarEye, and LeadIQ among its SaaS portfolio in India, has been lookin...
- High sales, health focus make e-pharmacy hotE-pharmacy had over 3 million users before the pandemic struck in India, according to a white paper from industry body Ficci and market res...
Load More
